Paul, Weiss is advising Renaissance Partners, a leading investment firm based in Italy, on the English law financing aspects for its acquisition, alongside Aurora Growth Capital and the Pavese family, of Genetic S.p.A. Genetic is a leading Italian pharmaceutical contract development and manufacturing organization (CDMO) in the respiratory and ophthalmic therapeutic areas.
The Paul, Weiss team includes corporate partners Matthew Merkle, Neel Sachdev and Nicolò Ascione.
Related Insights
July 03, 2025
Phenna Group Completes Refinancing
June 26, 2025